Dolby Laboratories, Inc. (NYSE:DLB) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating ...

Sing Sing—A24’s acclaimed prison drama starring Best Actor Oscar nominee Colman Domingo—is new on digital streaming. Directed by Greg Kwedar, Sing Sing, opened in limited release in limited ...

Without a juggernaut like “Avatar,” this year’s visual effects Oscar race is proving a competitive one, with VFX branch members nominating the stellar work in “Alien: Romulus,” “Better ...

Dolby Laboratories, Inc. (NYSE:DLB) Q1 2025 Earnings Call Transcript January 29, 2025 Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.14, expectations were $1.07.

NEW YORK (AP) — Jacques Audiard’s “Emilia Pérez” is an Oscar contender unlike any other. It’s a musical, a trans parable, and a Mexico-set melodrama, all combined into one unique ...

Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.14, expectations were $1.07. Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories ...

“Our ecosystem is strong. Our momentum with creatives and distributors continues to build,” stated Kevin Yaman, CEO of Dolby Laboratories. “Dolby Atmos, Dolby Vision and Imaging patents are well ...

Kevin Yeaman; President, Chief Executive Officer, Director; Dolby Laboratories Inc Robert Park; Chief Financial Officer, Senior Vice President; Dolby Laboratories Inc Steven Frankel; Analyst; ...

Barrington analyst Patrick Sholl maintained a Buy rating on Dolby Laboratories (DLB – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at $80.63.

In a report released yesterday, Steve Frankel from Rosenblatt Securities reiterated a Buy rating on Dolby Laboratories (DLB – Research Report), with a price target of $100.00. The company’s ...